Bradykinin-mediated Angioedema

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Bradykinin-mediated Angioedema trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT07046806

Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients

To assess the efficacy of prophylactic treatment with deucrictibant extended release (XR) tablet versus placebo in preventing angioedema attacks, and to also as…

United States10 participantsStarted 2025-03-10

Treatment: Deucrictibant XR tablet, Placebo comparator to XR tablet

All recent trials (4 shown)

WithdrawnNot Applicable

NCT05304091

Characterization of Rhythmicity Profiles of Bradykinin-mediated Angioedema Attacks Using a Tracking Smartphone Applicati…

Bradykinin-mediated angioedema is a rare and disabling disease, characterized by the occurrence of attacks marked by localized swelling of skin, but also of the…

Location not specified0Started 2022-08

Treatment: Questionnaire on a smartphone application

CompletedPhase 4

NCT07290855

A Study to Evaluate the Safety and Efficacy of Icatibant in Patients With Bradykinin Induced Angioedema

This is a phase IV clinical study. The investigators collect patients with a diagnosis of bradykinin induced angioedema. For a specific study period and prospec…

Taiwan5 participantsStarted 2024-09-27

Treatment: Icatibant Injection (Icanticure®)

Bradykinin-mediated Angioedema

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients

All recent trials (4 shown)

Characterization of Rhythmicity Profiles of Bradykinin-mediated Angioedema Attacks Using a Tracking Smartphone Applicati…

A Study to Evaluate the Safety and Efficacy of Icatibant in Patients With Bradykinin Induced Angioedema

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients

All recent trials (4 shown)

Characterization of Rhythmicity Profiles of Bradykinin-mediated Angioedema Attacks Using a Tracking Smartphone Applicati…

A Study to Evaluate the Safety and Efficacy of Icatibant in Patients With Bradykinin Induced Angioedema

Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induc…